Industry
        Tensred plus®: an innovative formula to combat pre-hypertension.    
                                        Industry
                
            
                    
        Key outputs and innovations of direct relevance to food and agriculture from the H2020 funded MASTER project.    
                                        Industry
                
            
                    
        This partnership aims to leverage Microba's advanced technology platform for measuring the human gut microbiome to discover novel biomarkers for pancreatic cancer detection.     
        10 principles summarizing SynBalance's belief about taking care of people’s health.    
                                        Industry
                
            
                    
        This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology, which provides greater…    
                                        Industry
                
            
                    
        First and only FDA-approved orally administered microbiota-based therapeutic, validating Seres’ microbiome platform –    
                                        Industry
                
            
                    
        The VE303 study would be the first pivotal Phase 3 study of a therapeutic candidate based on a defined bacterial consortium, which Vedanta is pioneering as a next-generation approach to…    
                                        Industry
                
            
                    
        The bacterial strains in MB097 were identified by analysing the microbiome of patients in multiple studies of ICIs in melanoma.    
        Marco Caspani, Executive Director of the Microbiome Division of Sacco System, explains how the company is directing his efforts and strong focus to the field of Biotherapeutics with the launch of…    
                                        Industry
                
            
                    
        The first-in-human study double-blind, placebo controlled, 28-day crossover study of the safety and tolerability of SB-121